Q1 2025 Holdings
Filed 2025-05-15 | 83 holdings | $352.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $27.0K | 47,319 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $90.0K | 125,000 | 0.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $217.0K | 140,000 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $221.9K | 38,000 | 0.1% |
| Biomx Inc | COM NEW | 09090D301 | $222.9K | 401,136 | 0.1% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $279.8K | 137,174 | 0.1% |
| Sutro Biopharma Inc | COM | 869367102 | $284.4K | 437,079 | 0.1% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $316.0K | 224,081 | 0.1% |
| Compugen LTD(CGEN) | ORD | M25722105 | $397.7K | 272,402 | 0.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $411.8K | 142,000 | 0.1% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $453.0K | 600,000 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $459.0K | 450,000 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $465.8K | 340,000 | 0.1% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $471.0K | 150,000 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $603.1K | 51,500 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $686.0K | 80,799 | 0.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $726.3K | 522,500 | 0.2% |
| Polypid LTD(PYPD) | COM | M8001Q126 | $789.4K | 291,273 | 0.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $798.6K | 371,434 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $811.2K | 1,704,232 | 0.2% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $819.8K | 47,086 | 0.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $860.2K | 108,200 | 0.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $909.3K | 586,667 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $956.1K | 10,500 | 0.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $998.6K | 907,854 | 0.3% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $1.0M | 64,479 | 0.3% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.0M | 636,103 | 0.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.0M | 59,000 | 0.3% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.1M | 245,000 | 0.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.1M | 304,752 | 0.3% |
| Alector Inc(ALEC) | COM | 014442107 | $1.1M | 912,928 | 0.3% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $1.1M | 2,511,374 | 0.3% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $1.2M | 95,290 | 0.3% |
| Palvella Therapeutics Inc(PVLA) | COM | 697947109 | $1.2M | 43,348 | 0.3% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.3M | 213,347 | 0.4% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $1.3M | 378,083 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.3M | 130,316 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.4M | 242,000 | 0.4% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.5M | 156,533 | 0.4% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.5M | 847,176 | 0.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.6M | 64,516 | 0.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.7M | 314,775 | 0.5% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $1.7M | 127,900 | 0.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $1.7M | 11,000 | 0.5% |
| Tela BIO Inc(TELA) | COM | 872381108 | $1.8M | 1,441,029 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $2.0M | 1,380,118 | 0.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.0M | 711,046 | 0.6% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.1M | 1,567,561 | 0.6% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $2.1M | 429,252 | 0.6% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.2M | 1,222,358 | 0.6% |